MEX3A and hepatocellular carcinoma: In this study, we examined the link between the methylation state of the Mex3a promoter in patients and other clinicopathological traits using MethyLight to detect the degree of Mex3a promoter methylation in HBV-associated HCC, chronic hepatitis B (CHB), and healthy controls (HCs).